Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 12, 1998
Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomasP Würl, A Meye, D Berger, et al.
Oncogene|June 13, 2000
DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinomaH Maacke, K Jost, S Opitz, et al.
Cancer Research|August 1, 1997
Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCRE Soeth, I Vogel, C Röder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Systemic and local immunosuppression in pancreatic cancer patientsW von Bernstorff, M Voss, S Freichel, et al.
Annals of Surgery|April 4, 1998
Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic markerA Schott, I Vogel, U Krueger, et al.
Oncogene|June 6, 2006
TRAIL promotes metastasis of human pancreatic ductal adenocarcinomaA Trauzold, D Siegmund, B Schniewind, et al.
Cell Death and Differentiation|April 10, 2010
Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activationM Ehrenschwender, D Siegmund, A Wicovsky, et al.
Oncogene|February 1, 1993
p53 and K-RAS alterations in pancreatic epithelial cell lesionsH Kalthoff, W Schmiegel, C Roeder, et al.
Oncogene|May 26, 1999
DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expressionI Schwarte-Waldhoff, S Klein, S Blass-Kampmann, et al.
Cancer Research|March 1, 1985
Monoclonal antibody-defined human pancreatic cancer-associated antigensW H Schmiegel, H Kalthoff, R Arndt, et al.
Pageof 12